{Reference Type}: Journal Article
{Title}: Effect of a Kinect-based exercise game on improving executive cognitive performance in community-dwelling elderly: case control study.
{Author}: Kayama H;Okamoto K;Nishiguchi S;Yamada M;Kuroda T;Aoyama T;
{Journal}: J Med Internet Res
{Volume}: 16
{Issue}: 2
{Year}: Feb 2014 24
{Factor}: 7.076
{DOI}: 10.2196/jmir.3108
{Abstract}: BACKGROUND: Decrease of dual-task (DT) ability is known to be one of the risk factors for falls. We developed a new game concept, Dual-Task Tai Chi (DTTC), using Microsoft's motion-capture device Kinect, and demonstrated that the DTTC test can quantitatively evaluate various functions that are known risk factors for falling in elderly adults. Moreover, DT training has been attracting attention as a way to improve balance and DT ability. However, only a few studies have reported that it improves cognitive performance.
OBJECTIVE: The purpose of this study was to demonstrate whether or not a 12-week program of DTTC training would effectively improve cognitive functions.
METHODS: This study examined cognitive functions in community-dwelling older adults before and after 12 weeks of DTTC training (training group [TG]) or standardized training (control group [CG]). Primary end points were based on the difference in cognitive functions between the TG and the CG. Cognitive functions were evaluated using the trail-making test (part A and part B) and verbal fluency test.
RESULTS: A total of 41 elderly individuals (TG: n=26, CG: n=15) participated in this study and their cognitive functions were assessed before and after DTTC training. Significant differences were observed between the two groups with significant group × time interactions for the executive cognitive function measure, the delta-trail-making test (part B-part A; F1,36=4.94, P=.03; TG: pre mean 48.8 [SD 43.9], post mean 42.2 [SD 29.0]; CG: pre mean 49.5 [SD 51.8], post mean 64.9 [SD 54.7]).
CONCLUSIONS: The results suggest that DTTC training is effective for improving executive cognitive functions.
BACKGROUND: Japan Medical Association Clinical Trial Registration Number: JMA-IIA00092; https://dbcentre3.jmacct.med.or.jp/jmactr/App/JMACTRS06/JMACTRS06.aspx?seqno=2682 (Archived by WebCite at http://www.webcitation.org/6NRtOkZFh).